1. Home
  2. CTKB vs EU Comparison

CTKB vs EU Comparison

Compare CTKB & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • EU
  • Stock Information
  • Founded
  • CTKB 1990
  • EU 2009
  • Country
  • CTKB United States
  • EU United States
  • Employees
  • CTKB N/A
  • EU N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EU Other Metals and Minerals
  • Sector
  • CTKB Health Care
  • EU Basic Materials
  • Exchange
  • CTKB Nasdaq
  • EU Nasdaq
  • Market Cap
  • CTKB 708.8M
  • EU 606.1M
  • IPO Year
  • CTKB 2021
  • EU N/A
  • Fundamental
  • Price
  • CTKB $6.27
  • EU $3.27
  • Analyst Decision
  • CTKB Strong Buy
  • EU Strong Buy
  • Analyst Count
  • CTKB 3
  • EU 2
  • Target Price
  • CTKB $9.17
  • EU $6.50
  • AVG Volume (30 Days)
  • CTKB 646.8K
  • EU 1.3M
  • Earning Date
  • CTKB 11-05-2024
  • EU 11-14-2024
  • Dividend Yield
  • CTKB N/A
  • EU N/A
  • EPS Growth
  • CTKB N/A
  • EU N/A
  • EPS
  • CTKB N/A
  • EU N/A
  • Revenue
  • CTKB $201,210,000.00
  • EU $44,972,063.00
  • Revenue This Year
  • CTKB $8.18
  • EU N/A
  • Revenue Next Year
  • CTKB $13.21
  • EU $109.91
  • P/E Ratio
  • CTKB N/A
  • EU N/A
  • Revenue Growth
  • CTKB 9.88
  • EU N/A
  • 52 Week Low
  • CTKB $4.66
  • EU $3.02
  • 52 Week High
  • CTKB $9.87
  • EU $5.05
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 45.80
  • EU 37.79
  • Support Level
  • CTKB $6.11
  • EU $3.11
  • Resistance Level
  • CTKB $6.78
  • EU $3.50
  • Average True Range (ATR)
  • CTKB 0.33
  • EU 0.18
  • MACD
  • CTKB -0.09
  • EU -0.01
  • Stochastic Oscillator
  • CTKB 13.95
  • EU 25.40

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.

Share on Social Networks: